Ferrochelatase deficiency in an infant with anemia and growth delay

Pediatrics
|May 1, 1979
PubMed

Insights

This study describes an infant with hypochromic anemia and iron overload due to ferrochelatase deficiency. Reduced iron enzyme activity likely caused the infant's growth retardation.

Area of Science:

  • Biochemistry
  • Pediatric Hematology

Background:

  • Ferrochelatase (heme synthetase) deficiency is a rare genetic disorder affecting heme synthesis.
  • Iron overload and hypochromic anemia are key clinical manifestations.

Observation:

  • A 5-month-old infant presented with symptoms of hypochromic anemia and iron overload.
  • The infant exhibited significant growth retardation.

Findings:

  • The infant's condition was attributed to a deficiency in ferrochelatase (heme synthetase) activity.
  • Decreased activity of iron-containing enzymes, without other identifiable causes, was identified as the primary factor contributing to growth retardation.

Implications:

  • This case highlights the critical role of ferrochelatase in iron metabolism and overall growth.
  • Understanding enzyme deficiencies is crucial for diagnosing and managing pediatric growth disorders.

Related Concept Videos